title: Newer antibiotics for serious gram-positive infections.
abstract: Four newer antibiotics are available to treat gram-positive bacterial infections that are resistant to traditional antibiotics and to vancomycin. They should preferably be used with the help of an infectious-disease consultant: specific therapy should be chosen on the basis of the bacteria involved, the site of infection, whether the patient has kidney or liver disease, other medications the patient is taking, and side effects that develop.
authors.affiliation: Department of Infectious Diseases, Cleveland Clinic Foundation, OH 44195, USA. frasert@ccf.org
authors.forename: Thomas G
authors.initials: TG
authors.lastname: Fraser
authors.forename: Christine
authors.initials: C
authors.lastname: Hansen
authors.forename: Jennifer K
authors.initials: JK
authors.lastname: Long
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000145:classification / Q000627:therapeutic use*; D017576:Daptomycin / Q000627:therapeutic use; D024881:Drug Resistance, Bacterial; D005260:Female; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D014640:Vancomycin / Q000627:therapeutic use; D014769:Virginiamycin / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D014769:Virginiamycin; C113825:quinupristin; D014640:Vancomycin; D017576:Daptomycin